97 related articles for article (PubMed ID: 15276071)
1. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes.
Miao B; Geng M; Li J; Li F; Chen H; Guan H; Ding J
Biochem Pharmacol; 2004 Aug; 68(4):641-9. PubMed ID: 15276071
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor (TCR)/CD3 is involved in sulfated polymannuroguluronate (SPMG)-induced T lymphocyte activation.
Miao B; Li J; Fu X; Ding J; Geng M
Int Immunopharmacol; 2005 Jul; 5(7-8):1171-82. PubMed ID: 15914322
[TBL] [Abstract][Full Text] [Related]
3. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.
Hui B; Xia W; Li J; Wang L; Ai J; Geng M
J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678
[TBL] [Abstract][Full Text] [Related]
4. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits T cell apoptosis by combating oxidative damage of mitochondria.
Miao B; Li J; Fu X; Gan L; Xin X; Geng M
Mol Pharmacol; 2005 Dec; 68(6):1716-27. PubMed ID: 16141310
[TBL] [Abstract][Full Text] [Related]
5. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
[TBL] [Abstract][Full Text] [Related]
6. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
7. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
Hui B; Li J; Geng MY
J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
[TBL] [Abstract][Full Text] [Related]
8. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of T cell function by a marine algae-derived sulfated polymannuroguluronate: in vitro analysis of novel mechanisms.
Xia W; Li J; Geng M; Xin X; Ding J
J Pharmacol Sci; 2005 Jan; 97(1):107-15. PubMed ID: 15665445
[TBL] [Abstract][Full Text] [Related]
10. Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad.
Wu YL; Ai J; Zhao JM; Xiong B; Xin XJ; Geng MY; Xin XL; Jiang HD
Acta Pharmacol Sin; 2011 May; 32(5):647-54. PubMed ID: 21499289
[TBL] [Abstract][Full Text] [Related]
11. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
12. Studies of marine sulfated polymannuroguluronate on endothelial cell proliferation and endothelial immunity and related mechanisms.
Wang L; Geng M; Li J; Guan H; Ding J
J Pharmacol Sci; 2003 Aug; 92(4):367-73. PubMed ID: 12939521
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates.
Wang L; Abbasi F; Gaigalas AK; Hoffman RA; Flagler D; Marti GE
Cytometry B Clin Cytom; 2007 Nov; 72(6):442-9. PubMed ID: 17474131
[TBL] [Abstract][Full Text] [Related]
16. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.
Naarding MA; Dirac AM; Ludwig IS; Speijer D; Lindquist S; Vestman EL; Stax MJ; Geijtenbeek TB; Pollakis G; Hernell O; Paxton WA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3367-74. PubMed ID: 17005819
[TBL] [Abstract][Full Text] [Related]
17. [Effect of sulfated polymannuroguluronate on Tat induced proinflammatory cytokines release in THP-1 cells and its mechanism of action].
Hui B; Geng MY; Li J
Yao Xue Xue Bao; 2006 Apr; 41(4):338-41. PubMed ID: 16856479
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
19. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function.
Kraus E; James W; Barclay AN
J Immunol; 1998 Jun; 160(11):5209-12. PubMed ID: 9605115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
